Design and synthesis of γ-dipeptide derivatives with submicromolar affinities for human somatostatin receptors

Angewandte Chemie - International Edition

Volumn 42, Issue 7, 2003, Pages 776-778

  Seebach, Dieter ^a   Schaeffer, Laurent ^a   Brenner, Meinrad ^a   Hoyer, Daniel ^b  

^a ETH ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Hormones; Peptides; Peptidomimetics; Somatostatin

Indexed keywords

AMINO ACIDS; CHEMICAL BONDS; HORMONES; SYNTHESIS (CHEMICAL);

MICROMOLAR AFFINITIES;

POLYPEPTIDES;

DIPEPTIDE; GAMMA DIPEPTIDE DERIVATIVE; NAPHTHYL GROUP; PEPTIDE HORMONE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; HUMAN; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; STRUCTURE ANALYSIS; SUBMICROMOLAR AFFINITY;

CIRCULAR DICHROISM; DIPEPTIDES; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; RECEPTORS, SOMATOSTATIN;

EID: 0037450183     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200390205     Document Type: Article

References (23)

1. M. Brenner, D. Seebach, Helv. Chim. Acta 2001, 84, 2155-2166.
2. For a non-peptidic analogue, see: R. W. Hoffmann, Angew. Chem. 2000, 112, 2134-2150; Angew. Chem. Int. Ed. 2000, 39, 2054-2070.
3. For a non-peptidic analogue, see: R. W. Hoffmann, Angew. Chem. 2000, 112, 2134-2150; Angew. Chem. Int. Ed. 2000, 39, 2054-2070.
4. 4, see: K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302-1304; Angew. Chem. Int. Ed. 1999, 38, 1223-1226; K. Gademann, M. Ernst, D. Seebach, D. Hoyer, Helv. Chim. Acta 2000, 83, 16-33; K. Gademann, T. Kimmerlin, D. Hoyer, D. Seebach, J. Med. Chem. 2001, 44, 2460-2468; D. Seebach, M. Rueping, P. I. Arvidsson, T. Kimmerlin, P. Micuch, C. Noti, D. Langenegger, D. Hoyer, Helv. Chim. Acta 2001, 84, 3503-3510.
5. 4, see: K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302-1304; Angew. Chem. Int. Ed. 1999, 38, 1223-1226; K. Gademann, M. Ernst, D. Seebach, D. Hoyer, Helv. Chim. Acta 2000, 83, 16-33; K. Gademann, T. Kimmerlin, D. Hoyer, D. Seebach, J. Med. Chem. 2001, 44, 2460-2468; D. Seebach, M. Rueping, P. I. Arvidsson, T. Kimmerlin, P. Micuch, C. Noti, D. Langenegger, D. Hoyer, Helv. Chim. Acta 2001, 84, 3503-3510.
6. 4, see: K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302-1304; Angew. Chem. Int. Ed. 1999, 38, 1223-1226; K. Gademann, M. Ernst, D. Seebach, D. Hoyer, Helv. Chim. Acta 2000, 83, 16-33; K. Gademann, T. Kimmerlin, D. Hoyer, D. Seebach, J. Med. Chem. 2001, 44, 2460-2468; D. Seebach, M. Rueping, P. I. Arvidsson, T. Kimmerlin, P. Micuch, C. Noti, D. Langenegger, D. Hoyer, Helv. Chim. Acta 2001, 84, 3503-3510.
7. 4, see: K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302-1304; Angew. Chem. Int. Ed. 1999, 38, 1223-1226; K. Gademann, M. Ernst, D. Seebach, D. Hoyer, Helv. Chim. Acta 2000, 83, 16-33; K. Gademann, T. Kimmerlin, D. Hoyer, D. Seebach, J. Med. Chem. 2001, 44, 2460-2468; D. Seebach, M. Rueping, P. I. Arvidsson, T. Kimmerlin, P. Micuch, C. Noti, D. Langenegger, D. Hoyer, Helv. Chim. Acta 2001, 84, 3503-3510.
8. 4, see: K. Gademann, M. Ernst, D. Hoyer, D. Seebach, Angew. Chem. 1999, 111, 1302-1304; Angew. Chem. Int. Ed. 1999, 38, 1223-1226; K. Gademann, M. Ernst, D. Seebach, D. Hoyer, Helv. Chim. Acta 2000, 83, 16-33; K. Gademann, T. Kimmerlin, D. Hoyer, D. Seebach, J. Med. Chem. 2001, 44, 2460-2468; D. Seebach, M. Rueping, P. I. Arvidsson, T. Kimmerlin, P. Micuch, C. Noti, D. Langenegger, D. Hoyer, Helv. Chim. Acta 2001, 84, 3503-3510.
9. For a review on somatostatin receptors, see: D. Hoyer, H. Luebbert, C. Bruns, Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 441-453; J. P. Hannon, C. Nunn, B. Stolz, C. Bruns, G. Weckbecker, I. Lewis, T. Troxler, K. Hurth, D. Hoyer, J. Mol. Neurosci. 2002, 18, 15-27. Classification and nomenclature of somatostatin receptors: D. Hoyer, G. I. Bell, M. Berelowitz, J. Epelbaum, W. Feniuk, P. P. Humphrey, A. M. O'Carroll, Y. C. Patel, A. Schonnbrunn, J. E. Taylor, T. Reisine, Trends Pharmacol. Sci. 1995, 16, 86-88.
10. For a review on somatostatin receptors, see: D. Hoyer, H. Luebbert, C. Bruns, Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 441-453; J. P. Hannon, C. Nunn, B. Stolz, C. Bruns, G. Weckbecker, I. Lewis, T. Troxler, K. Hurth, D. Hoyer, J. Mol. Neurosci. 2002, 18, 15-27. Classification and nomenclature of somatostatin receptors: D. Hoyer, G. I. Bell, M. Berelowitz, J. Epelbaum, W. Feniuk, P. P. Humphrey, A. M. O'Carroll, Y. C. Patel, A. Schonnbrunn, J. E. Taylor, T. Reisine, Trends Pharmacol. Sci. 1995, 16, 86-88.
11. For a review on somatostatin receptors, see: D. Hoyer, H. Luebbert, C. Bruns, Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 441-453; J. P. Hannon, C. Nunn, B. Stolz, C. Bruns, G. Weckbecker, I. Lewis, T. Troxler, K. Hurth, D. Hoyer, J. Mol. Neurosci. 2002, 18, 15-27. Classification and nomenclature of somatostatin receptors: D. Hoyer, G. I. Bell, M. Berelowitz, J. Epelbaum, W. Feniuk, P. P. Humphrey, A. M. O'Carroll, Y. C. Patel, A. Schonnbrunn, J. E. Taylor, T. Reisine, Trends Pharmacol. Sci. 1995, 16, 86-88.
12. For a review on somatostatin analogues, see: A. Janecka, M. Zubrzycka, T. Janecki, J. Pept. Res. 2001, 58, 91-107.
13. 2 position of the second γ-amino acid do stabilize the turn (see ref. [1] for more details).
14. M. Smreina, P. Majer, E. Majerova, T. A. Guerassina, M. A. Eissanstat, Tetrahedron 1997, 53, 12867-12874; S. Hanessian, R. Schaum, Tetrahedron Lett. 1997, 38, 163-166; T. Hintermann, K. Gademann, B. Jaun, D. Seebach, Helv. Chim. Acta 1998, 81, 983-1002.
15. M. Smreina, P. Majer, E. Majerova, T. A. Guerassina, M. A. Eissanstat, Tetrahedron 1997, 53, 12867-12874; S. Hanessian, R. Schaum, Tetrahedron Lett. 1997, 38, 163-166; T. Hintermann, K. Gademann, B. Jaun, D. Seebach, Helv. Chim. Acta 1998, 81, 983-1002.
16. M. Smreina, P. Majer, E. Majerova, T. A. Guerassina, M. A. Eissanstat, Tetrahedron 1997, 53, 12867-12874; S. Hanessian, R. Schaum, Tetrahedron Lett. 1997, 38, 163-166; T. Hintermann, K. Gademann, B. Jaun, D. Seebach, Helv. Chim. Acta 1998, 81, 983-1002.
17. The choice of a 2-naphthylacetyl group at the N-terminus was inspired by previous observations: The naphthyl group may be considered to mimic the benzyl side chain of a Phe residue, which precedes the Trp in the peptide chain of somatostatin: S. J. Hocart, R. Jain, W. A. Murphy, J. E. Taylor, B. Morgan, D. H. Coy, J. Med. Chem. 1998, 41, 1146-1154; A. J. Souers, A. A. Virgilio, A. Rosenquist, W. Fenuik, J. A. Ellman, J. Am. Chem. Soc. 1999, 121, 1817-1825.
18. The choice of a 2-naphthylacetyl group at the N-terminus was inspired by previous observations: The naphthyl group may be considered to mimic the benzyl side chain of a Phe residue, which precedes the Trp in the peptide chain of somatostatin: S. J. Hocart, R. Jain, W. A. Murphy, J. E. Taylor, B. Morgan, D. H. Coy, J. Med. Chem. 1998, 41, 1146-1154; A. J. Souers, A. A. Virgilio, A. Rosenquist, W. Fenuik, J. A. Ellman, J. Am. Chem. Soc. 1999, 121, 1817-1825.
19. B. H. Arison, R. Hirschmann, D. F. Veber, Bioorg. Chem. 1978, 7, 447-451; R. M. Freidinger, D. S. Perlow, W. C. Randall, R. Saperstein, B. H. Arison, D. F. Veber, Int. J. Pept. Protein Res. 1984, 23, 142-150; C. Wynants, D. Tourwe, W. Kazmierski, V. J. Hruby, G. Van Binst, Eur. J. Biochem. 1989, 185, 371.
20. B. H. Arison, R. Hirschmann, D. F. Veber, Bioorg. Chem. 1978, 7, 447-451; R. M. Freidinger, D. S. Perlow, W. C. Randall, R. Saperstein, B. H. Arison, D. F. Veber, Int. J. Pept. Protein Res. 1984, 23, 142-150; C. Wynants, D. Tourwe, W. Kazmierski, V. J. Hruby, G. Van Binst, Eur. J. Biochem. 1989, 185, 371.
21. B. H. Arison, R. Hirschmann, D. F. Veber, Bioorg. Chem. 1978, 7, 447-451; R. M. Freidinger, D. S. Perlow, W. C. Randall, R. Saperstein, B. H. Arison, D. F. Veber, Int. J. Pept. Protein Res. 1984, 23, 142-150; C. Wynants, D. Tourwe, W. Kazmierski, V. J. Hruby, G. Van Binst, Eur. J. Biochem. 1989, 185, 371.
22. 125I-Tyr), and SRIF is the acronym for somatostatin release inhibiting factor, 28 refers to the numbere of amino acids in the physiologically active form of the hormone.
23. J. Franckenpohl, P. I. Arvidsson, J. V. Schreiber, D. Seebach, ChemBioChem 2001, 2, 445-455.